← Open Payments lookup

SAHAR EFTEKHAR: Open Payments

NPI 1376819565 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,946 in 99 payments from 16 companies in 2025. Trend: 2023 $1,896 · 2024 $1,837 · 2025 $1,946

Food & beverage: $1,946
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.18$578
ABBVIE INC.24$363
Janssen Pharmaceuticals, Inc5$167
Lundbeck LLC21$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$154
Bausch Health US, LLC6$119
E.R. Squibb & Sons, L.L.C.4$88
Axsome Therapeutics, Inc.3$56
Supernus Pharmaceuticals, Inc.1$47
Biogen, Inc.2$47

Products named: REXULTI, VRAYLAR, SPRAVATO, CAPLYTA, APLENZIN, Auvelity, COBENFY, Qelbree.

Industry payments across IL — which companies pay providers there.